Vancomycin-resistant enterococci (VRE) first appeared in Europe during the 1980s. It rapidly spread to North America by the 1990s.
More than 50% of E. faecium in the United States are VRE.
E. faecalis tends to be susceptible to vancomycin.
Most frequent form of VRE infection: UTI, followed by catheter line associated bacteremia (i.e hemodialysis, central lines).
Treatment for VRE: daptomycin, linezolid, and tigecycline. Susceptible strains may be treated with ampicillin.
The two drugs are not interchangeable nor dose equivalents. Mycophenolate mofetil is a semi synthetic…
Two systematic reviews have assessed the diagnostic accuracy of elements of the medical history, physical…